Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SANAD-II: Levetiracetam and zonisamide versus standard treatments for epilepsy
2012-001884-64Phase 4Completed
- Sponsor
- University of Liverpool
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of levetiracetam, zonisamide, lamotrigine and valproic acid in epilepsy (7 arms), sponsored by University of Liverpool. Primary endpoint: Time to 12-month remission. Started May 2012; status: completed.
02
Drugs
levetiracetamzonisamidelamotriginevalproic acid
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2012-001884-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001884-64.